What is the appropriate dosing of prazosin (Prazosin) for post-traumatic stress disorder (PTSD)-related nightmares in a patient taking sertraline (Sertraline) 200 milligrams, and what should be monitored?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a patient with PTSD experiencing nightmares despite sertraline 200 mg and prazosin 10 mg nightly, the prazosin dose should be increased gradually to 15 mg nightly for two weeks, then reassessing symptoms, as the recommended therapeutic dose range for PTSD-related nightmares is typically 3-15 mg at bedtime, with some patients requiring up to 20 mg for optimal effect, as suggested by the American Academy of Sleep Medicine position paper 1.

Key Considerations

  • The patient's current dose of prazosin is 10 mg nightly, which may not be sufficient to achieve optimal efficacy in reducing PTSD-related nightmares.
  • Gradually increasing the prazosin dose to 15 mg nightly, as recommended by the American Academy of Sleep Medicine position paper 1, may help improve symptoms.
  • It is essential to monitor the patient's blood pressure regularly, especially after dose increases, as prazosin can cause hypotension and dizziness, as noted in the study by Raskind et al. 1.
  • Other side effects to monitor include headache, drowsiness, and nasal congestion, as reported in the study by Raskind et al. 1.

Monitoring and Titration

  • Blood pressure should be checked regularly, especially after dose increases, to minimize the risk of hypotension and dizziness.
  • Patients should be advised to rise slowly from sitting or lying positions to minimize dizziness risk, particularly after dose increases.
  • If nightmares persist and the patient tolerates the medication well, consider further titration to 20 mg, as some patients may require higher doses for optimal effect, as suggested by the study by Raskind et al. 1.

Mechanism of Action

  • Prazosin works by blocking alpha-1 adrenergic receptors, which reduces the noradrenergic hyperactivity associated with PTSD nightmares, as explained in the American Academy of Sleep Medicine position paper 1.

Additional Treatment Options

  • Cognitive behavioral therapy, exposure, relaxation, and rescripting therapy, and image rehearsal therapy may be considered as adjunctive treatments for PTSD-associated nightmares, as recommended by the American Academy of Sleep Medicine position paper 1.

From the Research

Appropriate Dosing of Prazosin for Nightmares in PTSD

  • The appropriate dosing of prazosin for nightmares in PTSD can start as low as 1 mg daily, with therapeutic benefits observed within one week of initiation 2.
  • The dose of prazosin can range from 1 to 16 mg/d, with varying degrees of efficacy in reducing nightmares 3.

Monitoring Patients Taking Prazosin

  • Patients taking prazosin should be monitored for orthostatic hypotension, which is the most frequently reported adverse event 2.
  • The efficacy of prazosin in reducing nightmares should be assessed, with outcomes measured in terms of nightmare frequency, distress, and intensity 4.

Comparison with Other Medications

  • Prazosin has been compared to other medications, including doxazosin, clonidine, tricyclic antidepressants, and atypical antipsychotics, with varying degrees of efficacy in reducing nightmares 5.
  • Other medications, such as hydroxyzine and nabilone, have shown promise in reducing nightmares, but more research is needed to confirm their efficacy 4.

Considerations for Treatment

  • The treatment of nightmares in PTSD should be individualized, taking into account the patient's specific needs and medical history 5.
  • The use of prazosin and other medications should be carefully monitored, with regular assessments of efficacy and adverse events 2, 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prazosin for treatment of nightmares related to posttraumatic stress disorder.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.